Watch our on-demand webinar:
Accelerating Cell Line Development
View webinar
About Us
Our Company
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Longmont Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Search
Search
Toggle Menu
Search
Search
Toggle Menu
About Us
Toggle Menu
Our Company
Executive Leadership
Locations
Toggle Menu
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
Toggle Menu
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Toggle Menu
Offerings
Toggle Menu
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Toggle Menu
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Toggle Menu
Press Releases
Events
Thought Leadership
Resources
Toggle Menu
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Toggle Menu
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Longmont Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Our Company
About Us
Our History
Mission & Values
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Policies
Environment, Health & Safety
Group Privacy Policies
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fact Sheets
Global Manufacturing Capabilities (PDF)
CHEF1
TM
Expression Technology (PDF)
Analytical, Formulation and Stability (PDF)
Process Development (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)
News
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
Join Us
Career Opportunities
What Drives Us
Life at a CDMO
Diversity, Equity and Inclusion
Meet Our Teams
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Thought Leadership & Other Media
Filter by Tag
Show All
AAV vector manufacturing
Biological Solutions
Cell & Gene Therapy
Company News
Events
Other Media
Thought Leadership
Virtual Site Tour
6 min read
High-yield plasmid production starts with cutting-edge upstream processing
June 7, 2023 at 8:37 AM
Thought Leadership
Read More
2 min read
Get to the GMP clinical stage quickly utilizing scale down models in Vector Production
May 17, 2023 at 7:09 AM
Thought Leadership
Read More
3 min read
cGMP Compliance in a Growing Biologics Market
May 1, 2023 at 1:04 PM
Thought Leadership
Read More
2 min read
Dynamic Binding Capacity: benefits & strategies of using it to create a more effective downstream process
April 6, 2023 at 8:29 AM
Thought Leadership
Read More
2 min read
CTO Interview: Managing Outsourcing in 2023
March 16, 2023 at 6:56 PM
Thought Leadership
Read More
2 min read
CDMO Outsourcing Trends & Benefits in the Biologics Manufacturing Industry
March 14, 2023 at 7:47 AM
Read More
1 min read
3 Important Factors that Drive Successful Orphan Drug Development & Manufacturing
February 27, 2023 at 5:56 PM
Read More
2 min read
Comparing Antibody Purification Methods: Protein A vs. Resin
February 24, 2023 at 12:18 PM
Read More
1 min read
AGC Biologics is Doubling Mammalian Capacity in Europe
January 9, 2023 at 1:43 PM
Read More
1 min read
White Paper: Producing Customized Viral Vectors that Respond to Market Demands
December 8, 2022 at 7:11 AM
Read More
1
2
3
Next
